...
首页> 外文期刊>Food Science & Nutrition >Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease
【24h】

Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease

机译:乳杆菌帕拉沙霉菌Jlus66通过非酒精脂肪肝疾病的大鼠调节肠道菌群来膨胀氧化应激和炎症

获取原文
           

摘要

The nonalcoholic fatty liver disease (NAFLD) is a progressive liver disease that affects the health of people in an increasing rate. In the current research, we investigated the beneficial effect of a novel probiotic strain L. paracasei Jlus66 (Jlus66) on rats with high‐fat diet (HFD)‐induced NAFLD. The intestinal flora of rats was analyzed based on V3‐V4 region 16S rDNA sequencing. Moreover, we measured the oxidative stress and inflammation factors in the liver using commercial ELISA kit, and the lipopolysaccharide (LPS) in serum with chromogenic end‐point tachypheus amebocyte lysate. Compared with the HFD‐induced group, Jlus66 treatment significantly decreased the malondialdehyde (MDA) level in the serum ( p ??0.05). Additionally, Jlus66 significantly enhanced the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px) in the liver and serum ( p ??0.05). Jlus66 administration also reduced the levels of tumor necrosis factor (TNF‐α) and interleukin‐6 (IL‐6), and inversely increased the interleukin‐10 (IL‐10) level in serum ( p ??0.05). Intestinal flora analysis results showed that Jlus66 can improve intestinal flora structure by increasing the abundance of gram‐positive flora such as Firmicutes, and decreasing gram‐negative flora such as Bacteroidetes, Proteobacteria, and Fusobacteria, and then reduced LPS concentration in the serum. So we concluded that Jlus66 can improve NAFLD by modulating the intestinal flora and followed reduction of oxidative stress (OxS) and inflammation.
机译:非酒精性脂肪肝疾病(NAFLD)是一种逐步影响人们健康的进步性肝病。在目前的研究中,我们研究了一种新型益生菌菌株L. paracasei Jlus66(JLUS66)对高脂饮食(HFD)诱导的NAFLD的大鼠的有益作用。基于V3-V4区域16S RDNA测序分析大鼠的肠菌群。此外,我们使用商业ELISA试剂盒测量肝脏中的氧化应激和炎症因子,以及血清中的脂多糖(LPS),具有发色终点Tachypheus Amebocyte裂解物。与HFD诱导的组相比,JLUS66治疗显着降低了血清中的丙二醛(MDA)水平(P?<?0.05)。此外,JLUS66显着提高了肝脏和血清中超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-PX)的活性(P?<β05)。 JLUS66管理还降低了肿瘤坏死因子(TNF-α)和白细胞介素-6(IL-6)的水平,并在血清中的白细胞介素-10(IL-10)水平增加(P?<β05)。肠道菌群分析结果表明,JLUS66通过增加革兰氏阳性菌群(如机械,克隆),植物,植物细菌等革兰氏阴性菌群和血清等革兰氏阴性菌群而改善肠道菌群结构,然后在血清中降低LPS浓度。因此,我们得出结论,JLUS66可以通过调节肠道菌群并随后降低氧化应激(OX)和炎症来改善NAFLD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号